Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-02-20 Sale | 2026-02-24 6:57 pm | MapLight Therapeutics Inc. | MPLT | Malenka Robert C. Director | 14,195 | $18.34 | $260,398 | 356,731 (Indirect Direct) | View |
| 2026-02-18 Purchase | 2026-02-20 6:25 pm | MapLight Therapeutics Inc. | MPLT | Pavlov George Director | 25,000 | $17.65 | $441,168 | 25,000 (Direct) | View |
| 2026-02-13 Sale | 2026-02-18 7:33 pm | MapLight Therapeutics Inc. | MPLT | Malenka Robert C. Director | 12,116 | $18.21 | $220,632 | 370,926 (Indirect Direct) | View |
| 2026-02-10 Purchase | 2026-02-12 5:45 pm | MapLight Therapeutics Inc. | MPLT | Garnett Timothy John Director | 14,124 | $17.89 | $252,678 | 63,649 (Indirect Direct) | View |
| 2026-02-10 Sale | 2026-02-12 5:45 pm | MapLight Therapeutics Inc. | MPLT | Malenka Robert C. Director | 6,863 | $18.12 | $124,329 | 383,042 (Indirect Direct) | View |
| 2026-02-02 Sale | 2026-02-04 9:15 pm | MapLight Therapeutics Inc. | MPLT | Malenka Robert C. Director | 7,040 | $18.02 | $126,861 | 389,905 (Indirect Direct) | View |
| 2026-01-28 Sale | 2026-01-30 8:50 pm | MapLight Therapeutics Inc. | MPLT | Malenka Robert C. Director | 34,398 | $18.49 | $635,857 | 396,945 (Indirect Direct) | View |
| 2025-10-28 Purchase | 2025-10-30 4:31 pm | MapLight Therapeutics Inc. | MPLT | Novo Holdings A/S 10% Owner | 952,941 | $17 | $16,199,997 | 3,686,622 (Direct) | View |
| 2025-10-28 Purchase | 2025-10-29 4:16 pm | MapLight Therapeutics Inc. | MLPT | Catalyst4 Inc. 10% Owner | 5,441,176 | $17 | $92,499,992 | 19,697,464 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-05 Option Award | 2026-02-09 5:50 pm | N/A 2036-02-04 | MapLight Therapeutics Inc. | MPLT | GILLIS JONATHAN CAAO and PAO | 30,475 | $0 | 278,978 (Direct) | View |
| 2026-02-05 Option Award | 2026-02-09 5:50 pm | N/A 2036-02-04 | MapLight Therapeutics Inc. | MPLT | Setia Vishwas Chief Financial Officer | 39,125 | $0 | 426,944 (Direct) | View |
| 2026-02-05 Option Award | 2026-02-09 5:50 pm | N/A 2036-02-04 | MapLight Therapeutics Inc. | MPLT | Lillie James Woodruff Chief Scientific Officer | 39,125 | $0 | 330,257 (Direct) | View |
| 2026-02-05 Option Award | 2026-02-09 5:50 pm | N/A 2036-02-04 | MapLight Therapeutics Inc. | MPLT | Kreitzer Anatol Chief Discovery Officer | 30,475 | $0 | 284,383 (Direct) | View |
| 2026-02-05 Option Award | 2026-02-09 5:50 pm | N/A 2036-02-04 | MapLight Therapeutics Inc. | MPLT | Hanson Kristopher General Counsel | 39,125 | $0 | 222,977 (Direct) | View |
| 2026-02-05 Option Award | 2026-02-09 5:50 pm | N/A 2036-02-04 | MapLight Therapeutics Inc. | MPLT | Foff Erin Pennock Chief Medical Officer | 67,600 | $0 | 458,075 (Direct) | View |
| 2026-02-05 Option Award | 2026-02-09 5:50 pm | N/A 2036-02-04 | MapLight Therapeutics Inc. | MPLT | Kroeger Christopher A. Chief Executive Officer | 117,100 | $0 | 1,844,896 (Direct) | View |
| 2026-01-27 Tax Withholding | 2026-01-29 4:30 pm | N/A N/A | MapLight Therapeutics Inc. | MPLT | Setia Vishwas Chief Financial Officer | 33,382 | $17.98 | 387,819 (Direct) | View |
| 2026-01-27 Tax Withholding | 2026-01-29 4:30 pm | N/A N/A | MapLight Therapeutics Inc. | MPLT | Lillie James Woodruff Chief Scientific Officer | 45,055 | $17.98 | 291,132 (Direct) | View |
| 2026-01-27 Tax Withholding | 2026-01-29 4:30 pm | N/A N/A | MapLight Therapeutics Inc. | MPLT | Kreitzer Anatol Chief Discovery Officer | 42,099 | $17.98 | 253,908 (Direct) | View |
| 2026-01-27 Tax Withholding | 2026-01-29 4:30 pm | N/A N/A | MapLight Therapeutics Inc. | MPLT | GILLIS JONATHAN CAAO and PAO | 22,050 | $17.98 | 248,503 (Direct) | View |
| 2026-01-27 Tax Withholding | 2026-01-29 4:30 pm | N/A N/A | MapLight Therapeutics Inc. | MPLT | Kroeger Christopher A. Chief Executive Officer | 204,146 | $17.98 | 1,727,796 (Direct) | View |
| 2026-01-27 Tax Withholding | 2026-01-29 4:30 pm | N/A N/A | MapLight Therapeutics Inc. | MPLT | Foff Erin Pennock Chief Medical Officer | 44,616 | $17.98 | 390,475 (Direct) | View |
| 2026-01-27 Tax Withholding | 2026-01-29 4:30 pm | N/A N/A | MapLight Therapeutics Inc. | MPLT | Hanson Kristopher General Counsel | 26,007 | $17.98 | 183,852 (Direct) | View |
| 2025-10-28 Conversion | 2025-10-30 4:31 pm | N/A N/A | MapLight Therapeutics Inc. | MPLT | Novo Holdings A/S 10% Owner | 48,659,559 | $0 | 3,686,622 (Direct) | View |
| 2025-10-28 Conversion | 2025-10-29 4:16 pm | N/A N/A | MapLight Therapeutics Inc. | MLPT | Catalyst4 Inc. 10% Owner | 28,512,576 | $0 | 19,697,464 (Indirect) | View |
| 2025-10-27 Option Award | 2025-10-28 4:15 pm | N/A 2035-10-26 | MapLight Therapeutics Inc. | MPLT | Garnett Timothy John Director | 31,898 | $0 | 31,898 (Direct) | View |
| 2025-10-27 Option Award | 2025-10-28 4:15 pm | N/A 2035-10-26 | MapLight Therapeutics Inc. | MPLT | Walker Maria C Director | 31,898 | $0 | 31,898 (Direct) | View |
| 2025-10-27 Option Award | 2025-10-28 4:15 pm | N/A 2035-10-26 | MapLight Therapeutics Inc. | MPLT | Hanson Kristopher General Counsel | 137,144 | $0 | 137,144 (Direct) | View |
| 2025-10-27 Option Award | 2025-10-28 4:15 pm | N/A 2035-10-26 | MapLight Therapeutics Inc. | MPLT | GILLIS JONATHAN CAAO and PAO | 154,587 | $0 | 154,587 (Direct) | View |
| 2025-10-27 Option Award | 2025-10-28 4:15 pm | N/A 2035-10-26 | MapLight Therapeutics Inc. | MPLT | Kreitzer Anatol Chief Discovery Officer | 182,005 | $0 | 182,005 (Direct) | View |
| 2025-10-27 Option Award | 2025-10-28 4:15 pm | N/A 2035-10-26 | MapLight Therapeutics Inc. | MPLT | Lillie James Woodruff Chief Scientific Officer | 164,562 | $0 | 164,562 (Direct) | View |
| 2025-10-27 Option Award | 2025-10-28 4:15 pm | N/A 2035-10-26 | MapLight Therapeutics Inc. | MPLT | Setia Vishwas Chief Financial Officer | 219,398 | $0 | 219,398 (Direct) | View |
| 2025-10-27 Option Award | 2025-10-28 4:15 pm | N/A 2035-10-26 | MapLight Therapeutics Inc. | MPLT | Foff Erin Pennock Chief Medical Officer | 244,310 | $0 | 244,310 (Direct) | View |
| 2025-10-28 Conversion | 2025-10-28 4:15 pm | N/A N/A | MapLight Therapeutics Inc. | MPLT | Malenka Robert C. Director | 69,372 | $0 | 570,953 (Indirect) | View |
| 2025-10-27 Option Award | 2025-10-28 4:15 pm | N/A 2035-10-26 | MapLight Therapeutics Inc. | MPLT | Malenka Robert C. Director | 174,000 | $0 | 570,953 (Direct) | View |
| 2025-10-28 Conversion | 2025-10-28 4:15 pm | N/A N/A | MapLight Therapeutics Inc. | MPLT | Kroeger Christopher A. Chief Executive Officer | 69,372 | $0 | 1,246,942 (Direct) | View |
| 2025-10-27 Option Award | 2025-10-28 4:15 pm | N/A 2035-10-26 | MapLight Therapeutics Inc. | MPLT | Kroeger Christopher A. Chief Executive Officer | 1,141,857 | $0 | 1,246,942 (Direct) | View |
Ownership | 2025-10-27 5:12 pm | N/A N/A | MapLight Therapeutics Inc. | MLPT | Catalyst4 Inc. 10% Owner | 0 | $0 | 14,256,288 (Indirect) | View |
Ownership | 2025-10-27 5:00 pm | N/A N/A | MapLight Therapeutics Inc. | MPLT | Novo Holdings A/S 10% Owner | 0 | $0 | 2,733,681 (Direct) | View |
Ownership | 2025-10-27 4:50 pm | N/A N/A | MapLight Therapeutics Inc. | MPLT | Hanson Kristopher General Counsel | 0 | $0 | 226,094 (Direct) | View |